Besifloxacin hydrochloride

Besifloxacin Hydrochloride is the hydrochloride salt form of besifloxacin, a synthetic fourth-generation fluoroquinolone antibiotic, with broad spectrum antibacterial activity. Upon administration, besifloxacin targets, binds to and inhibits both bacterial DNA gyrase, an enzyme essential for DNA replication, transcription and repair of bacterial DNA, and bacterial topoisomerase IV, an enzyme required for partitioning of the chromosomal DNA during bacterial cell division. It is grouped under the following drug class(es): Fluoroquinolones, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as antibacterials. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Besivance, 3-Quinolinecarboxylic acid, 7-((3R)-3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo- and monohydrochloride. Its PubChem CID is 10224595.